Sally Alrabaa, MD
Infectious Disease · Tampa, FLNPI 1912071994
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $246,950 of the $250,349 with a category attached, or 98.6%. Xtant Medical Inc accounts for 98.6% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $189,700, more than ten times the $3,268 reported in 2019. Among infectious disease clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 19 payments — averaging $13,176 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Xtant Medical Inc$247K
- F. Hoffmann-la Roche AG$3K
- Boston Scientific$113
- Merck$18
What the payments were for
- Consulting fees$246,95099%
- Speaking & faculty fees$3,2681%
- Food & beverage$1130%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Xtant Medical Inc | 15 | $246,950 |
| F. Hoffmann-la Roche AG | 2 | $3,268 |
| Boston Scientific | 1 | $113 |
| Merck | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$250,349 in reported general payments places this provider in the 95th percentile of 669 infectious disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefazolin Sodium | 19 | $575 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Tampa
- Beata CasanasTampa$227K
- Michael DunnTampa$45K
- Brahm SegalTampa$31K
- Margarita CancioTampa$23K
- Pamela NoelTampa$22K
- Lennox ArchibaldGainesville$2.1M
- Moti RamgopalFort Pierce$1.1M
- Juan DiazAltamonte Springs$980K
- Charlotte-Paige RolleOrlando$619K
- Kenneth AlexanderOrlando$474K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.